ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3133

Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis

WEIYU HAN1, Graeme Jones2 and Changhai Ding2, 1Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, 2Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Imaging, MRI and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: Osteoarthritis – Clinical Aspect II: Treatment and Imaging

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Infrapatellar fat pad (IPFP), a local adipose tissue, may have important contributions to knee osteoarthritis (OA). IPFP signal intensity alterations on MRI may represent pathological changes such as inflammation and oedema. This study aims to describe the associations between quantitative measures of infrapatellar fat pad (IPFP) signal intensity alterations and knee structural and symptomatic abnormalities in patients with symptomatic knee OA.

Methods: 261 participants (mean age 63.0 ± 7.2 years) with symptomatic knee OA (assessed according to American College of Rheumatology criteria) were selected from a randomized controlled trial. IPFP signal intensity alteration was quantitatively measured on T2-weighted fat-saturated MRI using MATLAB. These included the mean value [Mean (IPFP)] and standard deviation [sDev (IPFP)] of whole IPFP signal intensity, median value [Median (H)] and upper quartile value [UQ (H)] of high signal intensity, volume of high signal intensity regions [Volume (H)] and the ratio of Volume (H) to volume of whole IPFP [Percentage (H)] and Clustering factor (H) representing clustering effect of high signal intensity. Signal intensity alteration (SIA) was also measured semi-quantitatively (grade 0-3). Cartilage defects, bone marrow lesions (BMLs) and radiographic OA (ROA) were measured. All measures except ROA were performed at both baseline and 24 months later. Linear regression analyses were performed after adjustment for age, sex, BMI, and/or intervention.

Results: Two hundred and sixty one participants (mean age 63.0 ± 7.2 years) participated in this study. There were no significant differences in demographic factors (age, sex, and BMI) between these participants and those unselected. sDve (IPFP), Median (H), UQ (H), Volume (H), Percentage (H) and Clustering factors (H) were associated with increased ROA at baseline in multivariable analyses. In the linear mixed-effects model, these measures were significantly and positively associated with cartilage defects and BMLs over 2 years in multivariable analyses. Mean (IPFP), sDev (IPFP), Median (H) and UQ (H) were also significantly associated with increased knee pain over 2 years (Table 1).

Conclusion: Quantitative measures of signal intensity alteration in IPFP were associated with knee structural and symptomatic abnormalities in patients with symptomatic knee OA, suggesting that IPFP signal intensity alterations may have a role to play in knee OA progression. Table 1. Associations of IPFP signal intensity alteration with cartilage defects and bone marrow lesions

Cartilage defects*

Bone marrow lesions*

β (95% CI)

β (95% CI)

Mean (IPFP)

3.18 (-4.74, 11.10)

16.36 (6.27, 26.46)

sDev (IPFP)

31.39 (15.87, 46.90)

48.27 (31.19, 65.34)

Median (H)

6.46 (1.76, 11.16)

13.91 (8.49, 19.33)

UQ (H)

4.71 (1.17, 8.26)

10.06 (5.99, 14.14)

Volume (H)

1.33 (0.66, 1.99)

1.17 (0.46, 1.87)

Percentage (H)

37.91 921.64, 54.18)

46.36 (26.04, 66.69)

Clustering factor (H)

0.78 (0.44, 1.13)

1.16 (0.74, 1.58)

SIA

0.57 (0.30, 0.84)

0.83 (0.51, 1.15)

*Adjusted for age, sex, BMI, treatment allocation and randomization.


Disclosure: W. HAN, None; G. Jones, None; C. Ding, None.

To cite this abstract in AMA style:

HAN W, Jones G, Ding C. Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/association-between-quantitatively-measured-infrapatellar-fat-pad-high-signal-intensity-alteration-and-knee-structural-and-symptomatic-abnormalities-in-patients-with-symptomatic-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-between-quantitatively-measured-infrapatellar-fat-pad-high-signal-intensity-alteration-and-knee-structural-and-symptomatic-abnormalities-in-patients-with-symptomatic-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology